Adults with long-duration type 2 diabetes have blunted glycemic and β-Cell function improvements after bariatric surgery

Obesity

Volumn 23, Issue 3, 2015, Pages 523-526

  Khanna, Vishesh ^a,b   Malin, Steven K ^c   Bena, James ^a   Abood, Beth ^a   Pothier, Claire E ^a   Bhatt, Deepak L ^d   Nissen, Steven ^a   Watanabe, Richard ^e   Brethauer, Stacy A ^a   Schauer, Philip R ^a   Kirwan, John P ^a   Kashyap, Sangeeta R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INCRETIN; INSULIN;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY WEIGHT; CELL FUNCTION; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HORMONE RESPONSE; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; WEIGHT REDUCTION; BODY MASS; DIABETES MELLITUS, TYPE 2; GLYCEMIC INDEX; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

ADULT; BARIATRIC SURGERY; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCEMIC INDEX; HUMANS; INCRETINS; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES;

EID: 84925268570     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21021     Document Type: Article

References (20)

1. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014; 370: 2002-2013.
2. Gavin TP, Ernst JM, Caudill SE, et al. Insulin sensitivity is related to glycemic control in type 2 diabetes and diabetes remission after Roux-en Y gastric bypass. Surgery 2014; 155: 1036-1043.
3. Aarts EO, Janssen J, Janssen IM, Berends FJ, Telting D, de Boer H,. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery. Obes Surg 2013; 23: 867-873.
4. Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabet Care 2013; 36: 2175-2182.
5. Malin SK, Samat A, Wolski K, et al. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy. Int J Obes 2014; 38: 364-370.
6. Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: A retrospective cohort study. Lancet Diabet Endocrinol 2014; 2: 38-45.
7. Matsuda M, DeFronzo RA,. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
8. Solomon TP, Malin SK, Karstoft K, Haus JM, Kirwan JP,. The influence of hyperglycemia on the therapeutic effect of exercise on glycemic control in patients with type 2 diabetes mellitus. JAMA Intern Med 2013; 173: 1834-1836.
9. Malin SK, Haus JM, Solomon TP, Blaszczak A, Kashyap SR, Kirwan JP,. Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes. Am J Physiol Endocrinol Metab 2013; 305: E1292-E1298.
10. Raghow R,. Bariatric surgery-mediated weight loss and its metabolic consequences for type-2 diabetes. World J Diabetes 2013; 4: 47-50.
11. Jackness C, Karmally W, Febres G, et al. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell function in type 2 diabetic patients. Diabetes 2013; 62: 3027-3032.
12. Holst JJ,. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. Curr Opin Pharmacol 2013; 13: 983-988.
13. Dutia R, Brakoniecki K, Bunker P, et al. Limited recovery of beta-cell function after gastric bypass despite clinical diabetes remission. Diabetes 2014; 63: 1214-1223.
14. Habegger KM, Heppner KM, Amburgy SE, et al. GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats. Diabetes 2014; 63: 505-513.
15. Lee YS, Jun HS,. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells. Metabolism 2014; 63: 9-19.
16. Jimenez A, Mari A, Casamitjana R, Lacy A, Ferrannini E, Vidal J,. GLP-1 and glucose tolerance after sleeve gastrectomy in morbidly obese subjects with type 2 diabetes. Diabetes 2014; 63: 3372-3377.
17. Wood GC, Gerhard GS, Benotti P, et al. Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: A retrospective cohort analysis. Ann Surg 2014; 261: 125-128.
18. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC,. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10 Suppl 4: 32-42.
19. Kitamura T,. The role of FOXO1 in beta-cell failure and type 2 diabetes mellitus. Nat Rev Endocrinol 2013; 9: 615-623.
20. Malin SK, Solomon TP, Blaszczak A, Finnegan S, Filion J, Kirwan JP,. Pancreatic beta-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes. Am J Physiol Endocrinol Metab 2013; 305: E1248-E1254.